"Breakthrough Peptide Reverses Alzheimer's Symptoms"
Researchers at the Okinawa Institute of Science and Technology have developed a synthetic peptide, PHDP5, that reverses Alzheimer's symptoms in mice by enhancing synaptic function. The peptide can cross the blood-brain barrier and is most effective when administered early, potentially delaying cognitive decline. This breakthrough could lead to new therapies for Alzheimer's, with human trials on the horizon.